SEC Form 4 · accession 0000899243-19-007044
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James N Wilson
Director
Period of report
Mar 7, 2019
Accepted (ET)
Mar 11, 2019 · 5:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 7, 2019 | M | 105,782 | $2.30 | A | 115,782 | D | |
| Common StockF1 | holding | — | — | — | 1,331,574 | I | James N. Wilson and Pamela D. Wilson Trust | |
| Common StockF1 | holding | — | — | — | 901,067 | I | James and Pamela Wilson Family Partners |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.30 | Mar 7, 2019 | M | 105,782 | D | — | Dec 3, 2019 | Common Stock | 105,782 | 284,218 | D |
Explanation of responses
- F1Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
- F2Fully exercisable.